Osteoarthritis is a debilitating and painful wearing down of joint cartilage…
Category: Therapeutic Areas
Unless you’re working in a highly controlled environment like a cleanroom,…
The Centers for Disease Control and Prevention (CDC) describes human immunodeficiency virus (HIV)…
Are you interested in exploring plaque-associated inflammation? QPS Neuropharmacology, a division…
The results of a research collaboration between the neuroscience group of…
Ever wish that really big hill you always cycle up would…
Cannabinoid bioscience has come a long way. New York-based Axim Biotech…
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD)….
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
Webinars
A Gene Therapy Startup Engages in Horseplay to Test New Osteoarthritis Therapy
June 21, 2021
Osteoarthritis is a debilitating and painful wearing down of joint cartilage tissues. Every year, more than three million people in the U.S. (and millions more
The Need Grows for New Antifungal Therapies
May 10, 2021
Unless you’re working in a highly controlled environment like a cleanroom, it’s safe to assume you are surrounded by fungi. Millions of fungal species live
Human Immune System Beats HIV for the First Time
April 29, 2021
The Centers for Disease Control and Prevention (CDC) describes human immunodeficiency virus (HIV) as a virus that attacks the body’s immune system. Without treatment, HIV can cause
Interested in Plaque-Associated Inflammation?
July 19, 2019
Are you interested in exploring plaque-associated inflammation? QPS Neuropharmacology, a division of QPS (a leading CRO for drug development), is your partner for the visualization and
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the Department
Writing the Book on Beta-Alanine for Sports Performance: QPS MRA’s Doug Kalman Takes a Stand
August 11, 2015
Ever wish that really big hill you always cycle up would seem a little less hilly? Want to swing impressive poundage at your next kettlebell
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
August 11, 2015
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a multi-layered,
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET. These
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
